Review



vector vip substrate chromogen solution  (Vector Laboratories)


Bioz Verified Symbol Vector Laboratories is a verified supplier
Bioz Manufacturer Symbol Vector Laboratories manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Vector Laboratories vector vip substrate chromogen solution
    Vector Vip Substrate Chromogen Solution, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 286 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector vip substrate chromogen solution/product/Vector Laboratories
    Average 93 stars, based on 286 article reviews
    vector vip substrate chromogen solution - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    vector vip substrate chromogen solution  (Vector Laboratories)
    93
    Vector Laboratories vector vip substrate chromogen solution
    Vector Vip Substrate Chromogen Solution, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector vip substrate chromogen solution/product/Vector Laboratories
    Average 93 stars, based on 1 article reviews
    vector vip substrate chromogen solution - by Bioz Stars, 2026-03
    93/100 stars
    		  Buy from Supplier
    vector vip chromogen solution  (Vector Laboratories)
    86
    Vector Laboratories vector vip chromogen solution
    Iba1 immunostaining of free floating sections following different antigen methods. Wild type (WT) and APP/PS1 free floating 40 μm tissue sections were untreated (no treatment) or processed through single or combined antigen retrieval methods (trypsin-EDTA, 10 mM EDTA pH 6.0, formic acid, combined treatment) before immunostaining using anti-Iba1 antibody. Representative Iba1 immunostained images visualized using vector <t>VIP</t> as <t>the</t> <t>chromogen</t> taken from the temporal cortex are shown from (a) wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT trypsin-EDTA antigen retrieval, (d) APP/PS1 trypsin-EDTA antigen retrieval, (e) WT 10 mM EDTA, pH 6.0 antigen retrieval, (f) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval, (g) WT formic acid antigen retrieval, (h) APP/PS1 formic acid antigen retrieval, (i) WT combined treatment antigen retrieval, and (j) APP/PS1 combined treatment antigen retrieval.
    Vector Vip Chromogen Solution, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector vip chromogen solution/product/Vector Laboratories
    Average 86 stars, based on 1 article reviews
    vector vip chromogen solution - by Bioz Stars, 2026-03
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Iba1 immunostaining of free floating sections following different antigen methods. Wild type (WT) and APP/PS1 free floating 40 μm tissue sections were untreated (no treatment) or processed through single or combined antigen retrieval methods (trypsin-EDTA, 10 mM EDTA pH 6.0, formic acid, combined treatment) before immunostaining using anti-Iba1 antibody. Representative Iba1 immunostained images visualized using vector VIP as the chromogen taken from the temporal cortex are shown from (a) wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT trypsin-EDTA antigen retrieval, (d) APP/PS1 trypsin-EDTA antigen retrieval, (e) WT 10 mM EDTA, pH 6.0 antigen retrieval, (f) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval, (g) WT formic acid antigen retrieval, (h) APP/PS1 formic acid antigen retrieval, (i) WT combined treatment antigen retrieval, and (j) APP/PS1 combined treatment antigen retrieval.

    Journal: MethodsX

    Article Title: Iba1 immunoreactivity is enhanced following an antigen retrieval treatment with EDTA, pH 6.0

    doi: 10.1016/j.mex.2014.10.007

    Figure Lengend Snippet: Iba1 immunostaining of free floating sections following different antigen methods. Wild type (WT) and APP/PS1 free floating 40 μm tissue sections were untreated (no treatment) or processed through single or combined antigen retrieval methods (trypsin-EDTA, 10 mM EDTA pH 6.0, formic acid, combined treatment) before immunostaining using anti-Iba1 antibody. Representative Iba1 immunostained images visualized using vector VIP as the chromogen taken from the temporal cortex are shown from (a) wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT trypsin-EDTA antigen retrieval, (d) APP/PS1 trypsin-EDTA antigen retrieval, (e) WT 10 mM EDTA, pH 6.0 antigen retrieval, (f) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval, (g) WT formic acid antigen retrieval, (h) APP/PS1 formic acid antigen retrieval, (i) WT combined treatment antigen retrieval, and (j) APP/PS1 combined treatment antigen retrieval.

    Article Snippet: The free floating tissue or slide mounted tissue sections were rinsed four times with PBS only, then incubated for 5 min with a Vector VIP chromogen solution according to manufacturer's instructions (Vector VIP peroxidase substrate kit, Violet SK-4600, Vector Laboratories) to develop the immunostains.

    Techniques: Immunostaining, Plasmid Preparation

    Morphology of Iba1 immunoreactive microglia on slide mounted sections visualized after 10 mM EDTA, pH 6.0 antigen retrieval. Wild type (WT) and APP/PS1slide mounted brain sections, 10 μm, were untreated (no treatment) or processed for antigen retrieval using 10 mM EDTA, pH 6.0 before immunostaining using anti-Iba-1 antibody and visualized using vector VIP as the chromogen. Representative temporal cortex images are shown from (a) Wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT 10 mM EDTA, pH 6.0 antigen retrieval, and (d) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval conditions.

    Journal: MethodsX

    Article Title: Iba1 immunoreactivity is enhanced following an antigen retrieval treatment with EDTA, pH 6.0

    doi: 10.1016/j.mex.2014.10.007

    Figure Lengend Snippet: Morphology of Iba1 immunoreactive microglia on slide mounted sections visualized after 10 mM EDTA, pH 6.0 antigen retrieval. Wild type (WT) and APP/PS1slide mounted brain sections, 10 μm, were untreated (no treatment) or processed for antigen retrieval using 10 mM EDTA, pH 6.0 before immunostaining using anti-Iba-1 antibody and visualized using vector VIP as the chromogen. Representative temporal cortex images are shown from (a) Wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT 10 mM EDTA, pH 6.0 antigen retrieval, and (d) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval conditions.

    Article Snippet: The free floating tissue or slide mounted tissue sections were rinsed four times with PBS only, then incubated for 5 min with a Vector VIP chromogen solution according to manufacturer's instructions (Vector VIP peroxidase substrate kit, Violet SK-4600, Vector Laboratories) to develop the immunostains.

    Techniques: Immunostaining, Plasmid Preparation

    Aβ immunostaining of free floating sections following different antigen retrieval methods. Wild type (WT) and APP/PS1 free floating 40 μm tissue sections were untreated (no treatment) or processed through single or combined antigen retrieval methods (trypsin-EDTA, 10 mM EDTA pH 6.0, formic acid, combined treatment) before immunostaining using anti-Aβ antibody. Representative Aβ immunostained images visualized using vector VIP as the chromogen taken from the temporal cortex are shown from (a) wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT trypsin-EDTA antigen retrieval, (d) APP/PS1 trypsin-EDTA antigen retrieval, (e) WT 10 mM EDTA, pH 6.0 antigen retrieval, (f) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval, (g) WT formic acid antigen retrieval, (h) APP/PS1 formic acid antigen retrieval, (i) WT combined treatment antigen retrieval, and (j) APP/PS1 combined treatment antigen retrieval.

    Journal: MethodsX

    Article Title: Iba1 immunoreactivity is enhanced following an antigen retrieval treatment with EDTA, pH 6.0

    doi: 10.1016/j.mex.2014.10.007

    Figure Lengend Snippet: Aβ immunostaining of free floating sections following different antigen retrieval methods. Wild type (WT) and APP/PS1 free floating 40 μm tissue sections were untreated (no treatment) or processed through single or combined antigen retrieval methods (trypsin-EDTA, 10 mM EDTA pH 6.0, formic acid, combined treatment) before immunostaining using anti-Aβ antibody. Representative Aβ immunostained images visualized using vector VIP as the chromogen taken from the temporal cortex are shown from (a) wild type (WT) no treatment control, (b) APP/PS1 no treatment control, (c) WT trypsin-EDTA antigen retrieval, (d) APP/PS1 trypsin-EDTA antigen retrieval, (e) WT 10 mM EDTA, pH 6.0 antigen retrieval, (f) APP/PS1 10 mM EDTA, pH 6.0 antigen retrieval, (g) WT formic acid antigen retrieval, (h) APP/PS1 formic acid antigen retrieval, (i) WT combined treatment antigen retrieval, and (j) APP/PS1 combined treatment antigen retrieval.

    Article Snippet: The free floating tissue or slide mounted tissue sections were rinsed four times with PBS only, then incubated for 5 min with a Vector VIP chromogen solution according to manufacturer's instructions (Vector VIP peroxidase substrate kit, Violet SK-4600, Vector Laboratories) to develop the immunostains.

    Techniques: Immunostaining, Plasmid Preparation